It's necessary to go through the social consensus

for legislation to activate the generic substitution

Must pass the post-notice

It is argued that conflicts between doctors and pharmacists were not be resolved despite government intervention in order to legislate for the activation of the generic substitution, and that they should go through the social consensus process that took place at the time of the separation of prescribing and dispensing.

 

They say that citizens, doctors, pharmacists, and the government should come up with an agreement together because they are divided between doctors and pharmacists and repeatedly make unyielding claims.

 

In particular, the formation of a social consensus is inevitable because the issue of "prescribing active ingredient" is in conflict with the revitalization bill of the generic substitution.

 

The MOHW held a meeting of the KMA, the KHA and the Korean Pharmaceutical Association on the 26th, but failed to agree.

 

Eventually, the first subcommittee of the National Assembly's Health and Welfare Committee reviewed the agenda for revitalizing the generic substitution, which broke down the agreement between doctors and pharmacists.

 

Therefore, the National Assembly reviewed legislation to activate the generic substitution.

 

In 1999, the KMA and the Korean Pharmaceutical Association agreed on a generic substitution and the same level of social consensus that the agreement council had worked on in order to implement the separation of prescribing and dispensing.

 

Furthermore, the bill, which changes the name of the system from generic substitution to "same active patient dispensing" and extends pharmacists from doctors to the HIRA's DUR system, suggests that there is a serious conflict between the division of prescribing and dispensing.

 

It is unreasonable for doctors and pharmacists to simply try to resolve the same active dispensing, separation of prescribing and dispensing bill, which affects social consensus, with parliamentary legislation.

 

"From a doctor's point of view, changing a generic substitution to a same active ingredient dispensing is perceived as generic prescribing.

 

In particular, the generic substitution is a system that is deeply related to the separation of prescribing and dispensing.

 

"If the bill is passed right now, it will be a problem.

 

"How many doctors will agree to the bill that the National Assembly or the government hastily decided without an agreement?" "The general substitution issue is not a matter that can be proposed by a member of Parliament from a pharmacist and decided unilaterally by the National Assembly.

 

"We need to discuss more issues that have differences of opinion between professions." Professor Lee Jae-hyun of Sungkyunkwan University of Medicine said, "The perspective of the generic substitution depends on whether it is a job problem between doctors and pharmacists or a drug inventory problem at pharmacies.If looking at as a matter of doctors and pharmacists to operate a a social consensus on the impossibly difficult.

 

Regardless of the generic substitution, doctors and pharmacists had different opinions," he said, adding, "In terms of pharmacy drug inventory, we can find common ground." The arrangement of a list of local prescriptions was agreed upon at the time of the separation of prescribing and dispensing.

 

"It depends on which issue we focus on." An official from the Korean Pharmaceutical Association said, "The idea of a generic substitution as an active ingredient prescribing is too contradictory.

 

"The goal of the bill is to secure the finances of health insurance and promote national benefits by increasing the use of drugs already licensed through biological equivalence tests," he said.

 

"The general substitution sub-consultation ended without reaching an agreement, and theMOHW plans to report the details to the National Assembly." "It is not a matter of conflict between professional organizations, but a policy that the government should decide for the sake of the people." The official said, "The Ministry of Health and Welfare agreed to a clause that would expand the scope of post-notification.

 

"It is time for the National Assembly to pass even a partial passage of the extension of post-notification clause," he said.

 

"I think the Korean Pharmaceutical Association should join the discussion in that the formation of a social consensus is a division of preservation and dispensing revaluation." But it's going to take too long.